Clinical Trials on Oral Nutritional Supplement in Hong Kong
Total 798 results
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
-
Denali Therapeutics Inc.Completed
-
Bristol-Myers SquibbCompletedHIV Infections | Anorexia | CachexiaUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral Complications of Radiation TherapyUnited States
-
US Department of Veterans AffairsCompletedType 2 Diabetes MellitusUnited States
-
PfizerCompletedIdiopathic Parkinson DiseaseUnited States, Belgium
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Retrotope, Inc.CompletedFriedreich's AtaxiaUnited States
-
Green Cross CorporationUnknownWhooping Cough | Tetanus | DiphtheriaKorea, Republic of
-
Astellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
UCB Biopharma S.P.R.L.Completed
-
Monopar TherapeuticsTerminatedChemoradiotherapy-Induced Severe Oral MucositisUnited States, Spain, Germany, France, Puerto Rico
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
AstraZenecaCompletedObesity | OverweightUnited States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
DepomedCompletedParkinson's Disease | Motor FluctuationsUnited States
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
GlaxoSmithKlineTerminatedOsteoporosisGermany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
OPKO Health, Inc.CompletedBreast Cancer | Bone Neoplasms | Prostate Cancer | Hypocalcemia | Hyperparathyroidism, SecondaryUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, Japan, Malaysia, Taiwan, Thailand, Hong Kong
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Prothena Biosciences LimitedHoffmann-La RocheCompletedParkinson's DiseaseUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan, Malaysia, Taiwan, Korea, Republic of, Hong Kong
-
Podimetrics, Inc.CompletedFoot Ulcer, DiabeticUnited States
-
VA Office of Research and DevelopmentNational Institute of Mental Health (NIMH); University of California, Los AngelesCompletedSchizophrenia | Weight Gain | Chronic Illness | Psychotic DisorderUnited States
-
VIVUS LLCCompletedBlood PressureUnited States
-
Bastyr UniversityDiabetes Action Research and Education FoundationCompletedDiabetes | Insulin Resistance | Hypovitaminosis DUnited States
-
Crosstrees Medical Inc.CompletedPathologic Fracture of the Vertebra Due to OsteoporosisUnited States
-
Dart NeuroScience, LLCTerminated
-
SciClone PharmaceuticalsUnknown
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
Theravance BiopharmaCompletedParkinson Disease | Orthostatic Hypotension | Neurogenic Orthostatic Hypotension | Hypotension, Orthostatic | Pure Autonomic Failure | Multiple System Atrophy (MSA) With Orthostatic Hypotension | Pure Autonomic Failure With Orthostatic Hypotension | Parkinson Disease With Orthostatic HypotensionUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Romania, United States, Japan, Russian Federation, Spain, Canada, Germany, Latvia, Mexico, Brazil
-
Novartis PharmaceuticalsCompletedAlzheimer's DiseaseNetherlands, United States, Belgium, Germany, United Kingdom
-
Galera Therapeutics, Inc.CompletedOral MucositisUnited States, Puerto Rico, Canada
-
Novartis PharmaceuticalsCompletedPost-menopausal OsteoporosisColombia, Belgium, Sweden, Hong Kong, United States, Hungary, Switzerland, Australia, Germany, Italy, Canada, Poland, Argentina, Thailand, Norway, New Zealand, France, Finland
-
National Taiwan University HospitalCompletedParkinson's DiseaseTaiwan
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Belgium, Germany, Hong Kong, Netherlands, France, Australia, Canada, South Africa, United Kingdom, Spain, Poland, Switzerland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Viking Therapeutics, Inc.Active, not recruiting
-
AmgenCompletedSevere Familial HypercholesterolemiaItaly, Czechia, United States, Israel, New Zealand, South Africa, France, Spain, Australia, Belgium, Canada, Netherlands, Hong Kong, Brazil, United Kingdom, Greece, Japan, Lebanon
-
OPKO Health, Inc.Active, not recruitingChronic Kidney Diseases | Vitamin D Deficiency | Stage 5 Chronic Kidney Disease | Secondary Hyperparathyroidism Due to Renal CausesUnited States
-
AstraZenecaCompletedHypercholesterolemiaKorea, Republic of, Vietnam, Malaysia, Taiwan, Philippines, China, Indonesia, Thailand
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | Stage... and other conditionsUnited States, Canada, Hong Kong